Share: Facebook Twitter LinkedIn
Activity Provided By:

The Rx Consultant

Cholesterol Management - Understanding the 2018 Guideline

Access Activity

Overview / Abstract:

Cardiovascular disease (CVD), which includes high blood pressure, stroke, heart failure, and coronary heart disease, is prevalent and costly. Coronary heart disease is the most common form, accounting for 43% of all deaths attributed to CVD. The underlying pathophysiology of CVD is atherosclerosis; hence the term atherosclerotic cardiovascular disease (ASCVD). Risk factor management and treatment are essential to prevent CVD progression, cardiovascular events, and costly healthcare. It is important for both prescribers and pharmacists to educate patients about a heart healthy lifestyle and promote adherence to drug therapy to prevent disease progression and lower the costs associated with CVD.

In November 2018, the American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol guideline was published online. The writing committee included physicians from several specialty areas, pharmacists, a nurse practitioner, a physician assistant, and a layperson. In addition to the ACC/AHA, the writing committee included representatives from 10 other national organizations. The guideline provides an evidence-based and patient-centered approach to the assessment and treatment of ASCVD. The 2018 guideline builds on many of the concepts introduced in the 2013 ACC/AHA cholesterol guideline, including the emphasis on using a high or moderate-intensity statin as first-line therapy based on patient risk, the use of the 10-year ASCVD risk estimator for certain patients, measuring lipids to monitor response to therapy and adherence, and the patient-clinician discussion...


May 22, 2022


Pharmacy CPE





Credits / Hours




Presenters / Authors / Faculty

Kim K. Birtcher, PharmD, MS, BCPS (AQ Cardiology), CDE, FNLA, AACC is a Clinical Professor at the University of Houston College of Pharmacy. She is also a clinical pharmacist at Kelsey-Seybold Cardiology Clinic in Houston, Texas where she is responsible for the Secondary Prevention Lipid Clinic. Her teaching and research interests are in cardiovascular risk reduction and quality improvement initiatives. Dr. Birtcher is an active member in the American College of Cardiology, and she was on the writing committee for the 2018 ACC/AHA Cholesterol Guideline.

Activity Specialities / Related Topics

Cardiology / Cardiovascular

Keywords / Search Terms

Continuing Education Network Inc. Cholesterol, 2018 Guideline, Cholesterol Management -

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map